I am Gualter Macedo, from Vila do Conde. I lived in the United Kingdom for ten years, where I worked as a systems administrator. It was there that, after a shoulder pain that seemed to be nothing, I was diagnosed with multiple myeloma.
- Jun 2015Diagnosed with multiple myeloma, in the United Kingdom.
- 2017Return to Portugal and to Vila do Conde, my home town. I start being followed at São João Hospital, in Porto.
- 2015–2025Four lines of treatment, relapses, COVID-19 with an intensive care stay and septicaemia.
- Oct 2025Cell collection for CAR-T therapy — the first in Portugal in multiple myeloma.
- Dec 2025Infusion of the CAR-T cells at São João Hospital, through the SNS.
- Aug 2026Complete remission.
- Oct 2026Testimony at the 7th APCL Conference, at the Champalimaud Foundation.
If I were asked whether I ever believed I would reach complete remission, I confess I only truly started to believe it was possible when the treatment was offered to me. I have followed and pursued CAR-T since 2018, the year I first learned about this treatment.
One of the hardest things to understand and accept was realising that, before getting better, I would have to get worse. To go ahead with the treatment, I had to stop my medication and let the disease progress. And I got worse. In 11 years of illness, I had never faced anything so psychologically hard to overcome. I was saying goodbye to friends. I was afraid.
But ten days after the CAR-T cells were given, there was no longer any evidence of the plasmacytomas. They had vanished like smoke. Six months later came the news I had longed for: complete remission!
The remission is complete, but the fatigue and the pain have not gone away. That is why I never talk about a cure, but about survival with a better quality of life.
Read more
Being informed makes a difference. APCL's Handbook of the Rights of Haemato-Oncology Patients and Survivors was much needed: knowing what to do and how to do it.
Shared decisions. Today it is extremely important for the patient to question the doctor and for both to decide together. It is good to know there are several options and to understand that there is a path of survival we can walk and be part of.
Access to CAR-T. It is a treatment that represents the future, but it is already a reality today. There is still much to do — on costs, but also on human resources, namely the number of haematologists.
After 11 years of illness, I know I will never be exactly who I was again. But I also know I can be a different version of myself, a version that has been through a lot, that has learned to value every achievement and that today can look at the future with hope.
If there is one thing I would like you to take from my testimony, it is this: do not stop believing that a new chance can exist, even when the road seems to have no way out. Get informed, ask questions, find out about the options that exist and fight, together with your medical teams, for the possibilities that make sense for each of you.
Don't stop looking for your own jackpot. Mine came true. There is hope. There is a way forward.
— Gualter Macedo
“Waiting for CAR-T. Gualter's odyssey to silence multiple myeloma”Report by Tiago Ramalho, photography by Manuel Roberto. Full text reproduced with permission from Público · original in Público ↗
Público · Porto edition · 4 Jul 2026
ULS São João carries out the first CAR-T infusion to treat multiple myelomaNews on the hospital's home page about the first myeloma patient treated with CAR-T at São João · post on ULS São João's Facebook ↗
ULS São João · 7 Jan 2026
Multiple Myeloma: Why Does It Matter to Know About It?Fatigue, bone pain and recurring infections: the warning signs of the second most frequent blood cancer. Sponsored content, from the “Believe in a Future with Hope” campaign (GSK, with the support of Renascença).
Phoenix · 24 Nov 2025
ULS São João carries out the first CAR-T infusion and gets ready to move forward in multiple myelomaThe announcement that the hospital would start treating myeloma with CAR-T.
ULS São João (Facebook) · 20 Oct 2025
APCL National Conference: CAR-T therapies and funding in the SNSWith Gualter Macedo's testimony about complete remission.
Público · 6 Nov 2026
APCL brings together specialists and patients in Coimbra to discuss advances in multiple myelomaMedjournal · 12 Nov 2026
APCL brings together specialists and patients in Coimbra (News Farma)News Farma · Nov 2026
This portal exists because I was well treated and well looked after. I want to thank those who treated me and cared for me:
- São João Hospital (ULS São João) — the Clinical Haematology Department, Dr Rui Bergantim, the Immunohaemotherapy Department and, very especially, the nurses who looked after me during 21 days in hospital and almost nine years of appointments and treatments. People who know how to care.
- APCL — Portuguese Association Against Leukaemia — for supporting patients and for giving me a voice to share my testimony.
- APLL — Portuguese Association of Leukaemias and Lymphomas — for its work with patients and families.





Photos: Gualter Macedo, published on Facebook and used here with the permission of the people photographed.
Groups created by patients and families to share experiences. They are not run by this site: read each group's rules and do not share personal health data in public groups.
In Portuguese
See groups in Spanish, English and French →
List checked in November 2026. Know another group? Tell us on Facebook.
No testimonies have been published yet. Yours could be the first.
Patient, survivor, family member or carer: your experience can help someone who is just starting on this path. You can write, record a video, or both. Testimonies are read and watched before they are published. You can use only your first name or a pseudonym.
